Medical Properties Trust, Inc. (FRA:M3P)
Germany · Delayed Price · Currency is EUR 4.231
-0.040 (-0.94%)
Last updated: Jan 28, 2026, 9:15 AM CET
Medical Properties Trust Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Rental Revenue | 850.91 | 883.16 | 675.48 | 1,173 | 1,173 | 900.19 |
Other Revenue | 94.64 | 58.15 | 42.97 | 40.8 | 28.49 | 20.42 |
| 1,009 | 1,039 | 885.77 | 1,584 | 1,573 | 1,270 | |
Revenue Growth (YoY | 52.52% | 17.27% | -44.07% | 0.67% | 23.90% | 45.90% |
Property Expenses | 36.67 | 27.26 | 41.57 | 45.7 | 39.1 | 24.89 |
Selling, General & Administrative | 134.33 | 133.79 | 145.59 | 160.49 | 145.64 | 131.66 |
Depreciation & Amortization | 263.24 | 447.66 | 603.36 | 332.98 | 321.25 | 264.25 |
Total Operating Expenses | 434.24 | 608.7 | 827.92 | 539.17 | 505.99 | 420.8 |
Operating Income | 574.92 | 429.99 | 57.85 | 1,044 | 1,067 | 848.86 |
Interest Expense | -479.37 | -417.82 | -411.17 | -359.04 | -367.39 | -328.73 |
Currency Exchange Gain (Loss) | 1 | 1 | - | - | - | - |
Other Non-Operating Income | 30.42 | -14.27 | -59.41 | 15.34 | 45.7 | -6.78 |
EBT Excluding Unusual Items | 126.97 | -1.1 | -412.73 | 700.79 | 745.48 | 513.35 |
Gain (Loss) on Sale of Investments | 1,201 | -960.79 | 67 | - | - | - |
Gain (Loss) on Sale of Assets | 7.65 | 478.69 | -1.82 | 536.76 | 52.47 | -2.83 |
Asset Writedown | -1,946 | -1,825 | -339.51 | -268.38 | -39.41 | -19.01 |
Other Unusual Items | -55.54 | -55.59 | 0.29 | -9.45 | -27.65 | -28.18 |
Pretax Income | -666.18 | -2,364 | -686.77 | 959.72 | 730.89 | 463.33 |
Income Tax Expense | 39.68 | 44.1 | -130.68 | 55.9 | 73.95 | 31.06 |
Earnings From Continuing Operations | -705.86 | -2,408 | -556.09 | 903.82 | 656.94 | 432.27 |
Net Income to Company | -705.86 | -2,408 | -556.09 | 903.82 | 656.94 | 432.27 |
Minority Interest in Earnings | -1.35 | -1.98 | -0.38 | -1.22 | -0.92 | -0.82 |
Net Income | -707.21 | -2,410 | -556.48 | 902.6 | 656.02 | 431.45 |
Preferred Dividends & Other Adjustments | 0.74 | 0.95 | 1.64 | 1.6 | 2.16 | 2.11 |
Net Income to Common | -707.95 | -2,411 | -558.12 | 901 | 653.86 | 429.35 |
Net Income Growth | - | - | - | 37.59% | 52.05% | 15.15% |
Basic Shares Outstanding | 601 | 600 | 599 | 599 | 589 | 529 |
Diluted Shares Outstanding | 601 | 600 | 599 | 599 | 590 | 530 |
Shares Change (YoY) | 0.14% | 0.29% | -0.05% | 1.47% | 11.25% | 23.85% |
EPS (Basic) | -1.18 | -4.02 | -0.93 | 1.51 | 1.11 | 0.81 |
EPS (Diluted) | -1.18 | -4.02 | -0.93 | 1.50 | 1.11 | 0.81 |
EPS Growth | - | - | - | 35.13% | 37.04% | -6.90% |
Dividend Per Share | 0.320 | 0.460 | 0.880 | 1.160 | 1.120 | 1.080 |
Dividend Growth | -39.62% | -47.73% | -24.14% | 3.57% | 3.70% | 5.88% |
Operating Margin | 56.97% | 41.40% | 6.53% | 65.95% | 67.84% | 66.86% |
Profit Margin | -70.15% | -232.14% | -63.01% | 56.89% | 41.56% | 33.82% |
EBITDA | 823.27 | 713.74 | 387.98 | 1,390 | 1,401 | 1,125 |
EBITDA Margin | 81.58% | 68.72% | 43.80% | 87.78% | 89.05% | 88.59% |
D&A For Ebitda | 248.35 | 283.75 | 330.13 | 345.58 | 333.78 | 275.95 |
EBIT | 574.92 | 429.99 | 57.85 | 1,044 | 1,067 | 848.86 |
EBIT Margin | 56.97% | 41.40% | 6.53% | 65.95% | 67.84% | 66.86% |
Funds From Operations (FFO) | 31.89 | -1,400 | 287.79 | - | - | - |
FFO Per Share | - | -2.33 | 0.48 | - | - | - |
Adjusted Funds From Operations (AFFO) | - | -1,400 | 287.79 | - | - | - |
FFO Payout Ratio | 605.16% | - | 213.83% | - | - | - |
Effective Tax Rate | - | - | - | 5.83% | 10.12% | 6.70% |
Revenue as Reported | 933.52 | 995.55 | 871.8 | 1,543 | 1,545 | 1,249 |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.